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ATSAbstract Introduction: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumo-
nia (VAP) are important causes of morbidity and mortality despite improved antimicrobial therapy,
supportive care, and prevention. General risk factors for developing HAP include age older than
70 years, serious comorbidities, malnutrition, impaired consciousness, prolonged hospitalization
and COPD. The availability of valid criteria for deﬁning severe pneumonia would provide a more
reliable basis for improving patients risk assessment. The aim of this study was to assess the prog-
nostic value of 7 different scores: Pneumonia Severity Index (PSI), CURB 65, Modiﬁed ATS rule,
infectious Diseases Society of America/American Thoracic Society Consensus Guidelines (IDSA/
ATS), SMART COP, Simpliﬁed SMART-COP (SMART CO) and SOAR) in assessing the severity
of HAP and outcome of patients.
Methods: This is a prospective Cohort study performed on a sixty patients admitted to critical
care medicine department of Alexandria University Hospital in Egypt over 12 months. All patients
were diagnosed as HAP. Calculation of the mentioned 7 scores was done once diagnosis of HAP
was conﬁrmed.
Results: The Area Under the Curve was highest in SMART-cop (AUC= 0.820) followed by the
SMART-CO score (AUC := 0.807) and PSI score (AUC := 0.806). All the previous scores
SMART-cop score at Cutoff valueP 2, SMRT-Co Score at Cutoff valueP 2, Modiﬁed ATS score
at Cutoff valueP 0.5 and PSI (pneumonia severity index) at Cutoff valueP 3,. have the highest
sensitivity (sensitivity 100% for each) in predicting 28-day mortality, regarding Speciﬁcity,
SMART-cop score is the most speciﬁc one (Speciﬁcity = 93%) in predicting 28-day mortality
followed by Modiﬁed ATS score (Speciﬁcity = 90%). Regarding the duration of Mechanical
Ventilation, it was found that SMART-cop (R= 0.824, p= 0.0001) followed by IDSA/ATS scores
Table 1 Area Under the Curve.
Test result variable(s)
PSI (pneumonia severity index)
CurB-65
Modiﬁed ATS
IDSA/ATS
SOAR
SMART-cop
SMRT-Co Score
758 T.H. Al-Badawy et al.(R= 0.787, p= 0.0001) had the highest correlation in predicting duration of Mechanical
Ventilation in critically ill patient with VAP as a higher SMART-cop and IDSA/ATS score reﬂect
that the pneumonia was complicated with septic shock and respiratory failure.
Conclusions: SMART – cop score is the most sensitive score in predicting 28-day mortality in the
studied patient followed by SMART – co and PSI score). SMART-cop score is the most speciﬁc one
(Speciﬁcity = 93%) in followed by Modiﬁed ATS score (Speciﬁcity = 90%).
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Hospital-acquired (or nosocomial) pneumonia (HAP) is pneu-
monia that occurs 48 h or more after admission and did not
appear to be incubating at the time of admission. Ventilator-
associated pneumonia (VAP) is a type of HAP that develops
more than 48 hours after endotracheal intubation as deﬁned
by The 2005 American Thoracic Society/Infectious Diseases
Society of America (ATS/IDSA) [1].
HAP is the leading cause of death among hospital-acquired
infections, with estimates of HAP-associated mortality ranging
from 20% to 50%. While some studies indicate an attributable
mortality of 33%, another suggests that pneumonia is not a
signiﬁcant risk factor for death after adjusting for other predic-
tors of mortality. The highest risk for HAP is in patients on
mechanical ventilation (ie, VAP), in whom the entity has been
best studied [2,3].
There are many Risk factors for HAP which include [male
sex, coma, COPD (chronic obstructive pulmonary disease),
bronchoscopy, tracheostomy, use of antacids, serious disease
predating the onset of VAP, infection at other sites and dura-
tion of prior antibiotic use >4 days] [4].
Severity assessment of pneumonia is considered the key to
deciding the site of care and guiding both general management
and antibiotic treatment. Much contemporary research has
been directed toward the development of evidence-based mea-
sures of illness severity in community-acquired pneumonia
(CAP) by relating a number of clinical and laboratory features
to signiﬁcant outcomes, namely mortality [5].
The clinical pulmonary infection score (CPIS) has been
investigated in multiple trials but the evidence to date does
not support widespread use of the CPIS as a diagnostic, prog-
nostic, or therapeutic decision tool, because it is not an ade-
quate surrogate for the diagnosis of VAP. Its poor sensitivity
and speciﬁcity in most studies preclude its use as an accurate
noninvasive diagnostic device. Of all the components of theArea Std. error (a)
0.806 0.058
0.747 0.067
0.772 0.061
0.790 0.061
0.734 0.066
0.820 0.054
0.807 0.057CPIS, the measure of oxygenation provides the most informa-
tion as a time-dependent factor during early VAP for predict-
ing its outcome in response to treatment, and deriving a
complex score appears to be superﬂuous for this purpose [6].
Although the severity of HAP and its effect on the outcome
of critically ill patients is much more serious than CAP, yet no
formal scoring system – to my knowledge – has been created or
validated to stratify HAP which is really needed to tailor the
medical care and pick up more serious cases to be subjected
to more intensive therapy and care. Considering the overall
similar pathology in both categories of pneumonia (CAP &
VAP), the idea was to try the application of different scoring
systems designed mainly for CAP for risk stratiﬁcation of
VAP and check its validity for this purpose. The idea has been
raised in a single retrospective study published in 2011 by a
Chinese group who concluded that the CAP scores can be also
applied for HAP but they didn’t focus too much on the validity
of the each single score compared to others [7].
The aim of this study was to assess the prognostic value of
different scores including (PSI, CURB65, SMART COP,
SMART CO, MODIFIED ATS, IDSA/ATS and SOAR) in
patients with hospital acquired pneumonia in predicting
28 day mortality, days on mechanical ventilation and ICU
length of stay.
Patients and methods
This study had been conducted on 60 patients admitted to
Alexandria University Hospital Critical Care Medicine
Department in Egypt who developed hospital acquired pneu-
monia including ventilator associated pneumonia after
approval of the local ethics committee of the faculty of medi-
cine, Alexandria University. All patients met the criteria of
developing pneumonia after 48 h of admission and they had
new or progressive inﬁltrates on the chest X-ray with one of
the 3 requirements of: fever more than 37.8 C or purulentAsymptotic sig. (b) Asymptotic 95% conﬁdence interval
Lower bound Upper bound
0.000 0.691 0.920
0.001 0.616 0.878
0.000 0.651 0.892
0.000 0.670 0.910
0.002 0.605 0.863
0.000 0.714 0.926
0.000 0.695 0.919
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lung cancer and those who hadn’t the full data for scoring ful-
ﬁlled are excluded from the study.
The next 7 scores were recorded for each patient once the
diagnosis of HAP was established and the correlation with
the outcome parameters was performed using adequate statis-
tical analysis. The scores used were:
PSI (pneumonia severity index) score [8]: The score uses
demographics (whether someone is older, and is male or
female), the coexistence of co-morbid illnesses, ﬁndings on
physical examination and vital signs, and essential laboratory
ﬁndings. Patients could be stratiﬁed into ﬁve risk categories,
Risk Classes I–V, and that these classes could be used to pre-
dict 30-day survival.Step 1: Stratify to Risk Class I vs. Risk Classes II–V
Presence of:Over 50 years of age Yes/NoAltered mental status Yes/NoPulse P125/min Yes/No
Respiratory rate >30/min Yes/NoSystolic blood pressure <90 mm Hg Yes/NoTemperature <35 C or P40 C Yes/No
History of:Neoplastic disease Yes/NoCongestive heart failure Yes/NoCerebrovascular disease Yes/NoRenal disease Yes/NoLiver disease Yes/NoIf any ‘‘Yes", then proceed to Step 2If all ‘‘No” then assign to Risk Class IStep 2: Stratify to Risk Class II vs. III vs. IV vs. VDemographics Points assignedIf Male +Age (yr)If Female +Age (yr)  10
Nursing home resident +10ComorbidityNeoplastic disease +30Liver disease +20Congestive heart failure +10Cerebrovascular disease +10Renal disease +10Physical exam findingsAltered mental status +20Pulse P125/minute +20
Respiratory rate >30/minute +20Systolic blood pressure <90 mm Hg +15Temperature <35C or P40C +10
Lab and radiographic findingsArterial pH <7.35 +30Blood urea nitrogen P30 mg/dl
(9 mmol/liter)+20Sodium <130 mmol/liter +20Glucose P250 mg/dl (14 mmol/liter) +10
Hematocrit <30% +10Partial pressure of arterial O2 < 60 mmHg +10Pleural eﬀusion +10Arterial pH < 7.35
P+30<70= Risk Class II
P71–90 = Risk Class IIIP
91–130 = Risk Class IVP
>130 = Risk Class V*CURB-65, also known as the CURB criteria, The CURB-65
is based on the earlier CURB score and is recommended by the
British Thoracic Society for the assessment of severity of pneu-
monia [9–11]. The score is an acronym for each of the risk fac-
tors measured. Each risk factor scores one point, for a
maximum score of 5: Confusion of new onset, Urea greater
than 7 mmol/l (Blood Urea Nitrogen > 19), Respiratory rate
of 30 breaths per minute or greater, Blood pressure less than
90 mmHg systolic or diastolic blood pressure 60 mmHg or less
and Age 65 or older [1].
*Modiﬁed ATS rule: This rule is met if at least 2 of 3 minor
criteria assessed at admission (systolic blood pressure
<90 mmHg, multilobar (>2 lobes) involvement, PaO2/
FiO2 < 250), or 1 of 2 major criteria assessed at admission
or during follow up (requirement for mechanical ventilation
or septic shock) were present [2,3].
*IDSA/ATS refers to Infectious Diseases Society of
America/American Thoracic Society Consensus Guidelines
on the Management of Community-Acquired Pneumonia in
Adults [4]. In addition to the 2 major criteria (need for
mechanical ventilation and septic shock), an expanded set of
minor criteria [respiratory rateP30 breaths/min; arterial oxy-
gen pressure/fraction of inspired oxygen (PaO2/FiO2) ratio
6250; multilobar inﬁltrates; confusion; blood urea nitrogen
level P20 mg/dl; leucopenia resulting from infection; throm-
bocytopenia; hypothermia; or hypotension requiring aggres-
sive ﬂuid resuscitation].
*SOAR comprises systolic blood pressure, oxygenation,
age, and respiratory rate, severe pneumonia is then deﬁned
as the presence ofP 2 out of the 4 criteria. A score of one is
given for the presence of each of the following (dichotomized
variables): systolic BP < 90 mmHg; PaO2:FiO2 < 250;
ageP 65 years; and RRP 30/min [9].
*SMART-COP scores will be calculated as presented by
Charles, and consisted of systolic blood pressure (<90 mmHg,
2 points); multilobar chest radiography involvement (1 point);
low albumin level (<3.5 g/dl, 1 point); high respiratory rate
(650 years: P25 br/min,>50 years: P30 br/min; 1 point);
tachycardia (P125 bpm; 1 point); confusion (new onset; 1
point); poor oxygenation (650 years: PaO2 < 70 mmHg or
O2 saturation 6 93%,>50 years: PaO2 < 60 mmHg or O2
saturation 6 90%; 2 points); and low arterial pH (<7.35; 2
points) [12].
*SMRT-Co Score (Simpliﬁed SMART-COP) was designed
for more simpliﬁcation, and it excludes the results for albumin,
arterial pH, and PaO2 [12].
Statistical Analysis: Categorical variables were analyzed
using a chi-square test or Fisher’s exact test where appropriate,
and continuous variables were compared using Student’s t-test
or the Mann- Whitney U test. The discriminatory power of
each scoring index was measured by receiver operating charac-
teristic (ROC) curves. The area under the ROC curve (AUC)
was calculated to give an estimate of the overall accuracy of
each scoring index in predicting different patient outcomes
(28-days mortality). An area of 0.50 implies that the scoring
index is no better than chance, whereas an area of 1 implies
perfect accuracy. Sensitivity, speciﬁcity and accuracy were also
calculated as well with their 95% conﬁdence intervals for all
the scoring indices. All tests were two-tailed, and P
value < 0.05 was considered to be statistically signiﬁcant. All
760 T.H. Al-Badawy et al.statistical analyses were performed using the SPSS 14.0
software (SPSS Inc., Chicago, IL, USA) and the MedCalc
9.6.2.0 package (MedCalc Software, Mariakerke, Belgium).
Results
As shown in Table 1 and Fig. 1 it was found that the Area
Under the Curve was highest in SMART-cop (AUC :=
0.820) followed by the SMART-CO score (AUC := 0.807)
and PSI score(AUC := 0.806) (it means that SMART –cop
score is the most sensitive score in predicting 28 day mortality
in the studied patient followed by SMART – co and PSI
score). The Area Under the Curve (AUC) is a measure of
the accuracy of a test. It describes the relationships between
sensitivity and speciﬁcity.
As shown in Table 2 and Fig. 2 it was found that from all
the previous scores SMART-cop score at Cutoff valueP 2,
SMRT-Co Score at Cutoff valueP 2, Modiﬁed ATS score
at Cutoff valueP 0.5 and PSI (pneumonia severity index) at
Cutoff valueP 3, have the highest sensitivity (sensitivity
100% for each) in predicting 28-day mortality in the studied
group of patients. Regarding Speciﬁcity it was found that
SMART-cop score is the most speciﬁc one (Speciﬁcity = 93%)
in predicting 28-day mortality in the studied patients followed
by Modiﬁed ATS score (Speciﬁcity = 90%).
Table 3 shows the correlation between days of MV and dif-
ferent scores, it was found that there was a signiﬁcant correla-
tion between the scores and the duration of MV, the most
highly signiﬁcant correlation was found in SMART-cop
(R= 0.824) and IDSA/ATS scores (R= 0.787).
Table 4, shows the correlation between duration of ICU
stay and different scores, it was found that there was a signif-
icant correlation between the scores and the duration of ICUFig. 1 ROC Curve to determine the sensitivity and speciﬁcity ofstay, the most highly signiﬁcant correlation was found in
SMART-cop (R= 0.809, p= 0.0001) and IDSA/ATS scores
(R= 0.809, p= 0.0001) followed by SMRT-Co Score
(R= 0.806, p= 0.0001) and SOAR score (R= 0.704,
p= 0.0001).
Discussion
In the present study it was observed that there was a signiﬁcant
correlation between the pneumonia severity index score (PSI)
and mortality. The mortality rate at 28 days increased signiﬁ-
cantly as the PSI score is greater than risk class 4 R> 90)
p= 0.0001), as regarding sensitivity it was observed that PSI
score is sensitive in predicting mortality (AUC := 0.806) this
can be explained by the fact that higher PSI scores reﬂect that
this group of patients have one or more comorbidities rather
than pneumonia including (Neoplastic disease, Liver disease,
Congestive heart failure, Cerebro-vascular disease and Renal
disease) and also a higher PSI score reﬂects that pneumonia
was severe to the degree that the patient developed Systemic
Inﬂammatory Response Syndrome (SIRS) and/or sepsis. So
there was a higher risk of mortality among this group of
patients. However, PSI score is complicated to use, requiring
computation of a score based on 20 variables. Similar ﬁnding
were reported by workers like Wen-Feng et al. they conducted
a retrospective cohort study based on an inpatient database
from 6 medical centers in Taiwan and they found that PSI
(>90) has the highest sensitivity in predicting 28-days mortal-
ity (AUC: 0.70) among patients with Hospital acquired pneu-
monia (HAP) [7].
Almost Similar results can be observed in both studies with
SMART-cop score which showed a sensitivity of 100% with
scoreP 2 which could be explained by may parameters useddifferent score in relation to the outcome (28-day mortality).
Table 2 Cutoff value of different scores and the sensitivity
and speciﬁcity of each score.
Test result
variable(s)
Positive if
greater than
or equal to
Sensitivity Speciﬁcity Accuracy
PSI
(pneumonia
severity
index)
3.000 1.000 0.833 0.85
CurB-65 3.000 0.900 0.367 0.65
Modiﬁed
ATS
0.500 1.000 0.900 0.95
IDSA/ATS 3.000 0.967 0.767 0.82
SOAR 2.000 0.833 0.433 0.65
SMART-
cop
2.000 1.000 0.933 0.97
SMRT-Co
Score
2.000 1.000 0.500 0.79
Table 3 Correlation between duration of MV and different
scores.
Days of MV
PSI (pneumonia severity index) R 0.301(*)
p 0.019
CurB-65 R 0.634(**)
p 0.0001
Modiﬁed ATS R 0.541(**)
p 0.0001
IDSA/ATS R 0.787(**)
p 0.0001
SOAR R 0.666(**)
p 0.0001
SMART-cop R 0.824(**)
p 0.0001
SMRT-Co Score R 0.741(**)
p 0.0001
* Correlation is signiﬁcant at the 0.05 level (2-tailed).
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
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other scores using 4 or 5 parameters like CURB65 score which
have a sensitivity of 90% or SOAR which have the lowest sen-
sitivity of 83%. In terms of speciﬁcity SMART-cop again car-
ries a high speciﬁcity of 97% compared to only 83% for PSI
and subsequently it had also the highest accuracy by 97%.
SMART-COP Score has less popularity compared to PSI
or CURB 65 [13] which are more commonly used in CAP clas-
siﬁcation, this may be related to more items to be fulﬁlled in
SMART-cop but considering that we are dealing here with
HAP. The provision of the required data is not that difﬁcultFig. 2 The sensitivity andand mostly will be done as a routine part from the work up
of any case of HAP.
The same superiority of SMART- COP in the present study
on HAP had been validated in CAP studies as shown in
another study carried out on 335 patients with Community-
Acquired Pneumonia (CAP) it was found that SMART-COP
score was superior to the other prognostic scoring tools for
predicting need for Intensive Respiratory or Vasopressorspeciﬁcity of each score.
Table 4 Correlation between duration of ICU stay and
different scores.
Duration of ICU
PSI (pneumonia severity index) R 0.284(*)
p 0.028
CurB-65 R 0.655(**)
p 0.0001
Modiﬁed ATS R 0.555(**)
p 0.0001
IDSA/ATS R 0.809(**)
p 0.0001
SOAR R 0.704(**)
p 0.0001
SMART-cop R 0.809(**)
p 0.0001
SMRT-Co Score R 0.806(**)
p 0.0001
* Correlation is signiﬁcant at the 0.05 level (2-tailed).
** Correlation is signiﬁcant at the 0.01 level (2-tailed).
762 T.H. Al-Badawy et al.Support (IRVS) rather than mortality, with a sensitivity of
85%, compared with 55% for a CURB-65 P3 or a PSI
P class 4 [14]. Similar ﬁndings were reported by workers like
Brando-Neto et al., who conducted a prospective cohort study
on 53 H1N1 pneumonia patients. It was found that the
SMART-COP score was a better tool for screening in-
hospital case fatality compared with the Simple Triage Scoring
System (STSS) in patients with H1N1 pneumonia. The
SMART-COP had higher sensibility and negative predictive
values with consequently better accuracy than the STSS
(92% versus 71.4%, 90.4% versus 85.7%, and 83% versus
68%, respectively) [2].
Surprisingly, the ATS rule scoring system which was ini-
tially designed to decide need for ICU admission for CAP
patients carries also a very high sensitivity of 100%, speciﬁcity
of 90% and accuracy of 95%. Considering the simplicity of
calculation of this score with minimal number of items needed,
it should be considered also as a good option for classifying
HAP and predicting mortality.
All the studied scores except for PSI score showed a signif-
icant correlation with both the duration of mechanical ventila-
tion and duration of ICU stay while PSI score showed less
correlation with the duration of mechanical ventilation and
the duration of ICU stay. There is no clear explanation why
the PSI was not able to predict those 2 parameters like other
scores although a lot of points which can predict the severity
of illness and the probable long term stay on the ventilator
and subsequently in the ICU are included in that score. In
the present study it was observed that SMART-cop score
(R= 0.809) and IDSA/ATS score (R= 0.809) had the highest
correlation in predicting duration of ICU stay in critically ill
patients with HAP followed by SMRT-Co Score (R= 0.806)
and SOAR (R= 0.704). This was in agreement with the study
designed by Kuang-Yao Yang et al., it was observed that
SMART-COP (AUC: 0.84, 0.82), Modiﬁed ATS (AUC:
0.84, 0.82) and IDSA/ATS (AUC: 0.80, 0.79) performed better
(statistically signiﬁcant difference) than PSI, CURB-65, SOAR
and SMRT-CO. in predicting need for ICU admission andduration of ICU stay [7]. This again denotes the superiority
of SMART-COP as proved by both results to be the best score
in this point.
The general conclusion that almost all of the scores used for
CAP assessment could be also very valuable for HAP. Most of
the scores are sharing many points in common with some dif-
ferences, The SMART-COP showed higher performance in all
the studied outcome parameters compared to other scores. The
simpliﬁed form of SMART-COP which is SMRT-CO with
exclusion of 3 parameters (albumin, arterial pH, and PaO2)
did not show the same power which highlights the crucial
importance of those 3 parameters which might improve the
accuracy of other scores if also it is included there). However
further studies are still needed to validate the use of
SMART-COP regularly in the risk stratiﬁcation of patients
with HAP and VAP.
Limitations of the present study are related to its design. As
we only considered patients admitted to ICU, we may have
missed another category of patients that were diagnosed with
pneumonia while hospitalized in the ward for more than
48 h, as well as patients directly transferred from chronic
healthcare facilities to internal medicine wards which deﬁnitely
represent less sick patients with certainly lower scores. The
other limitation of the study is that we used the duration of
mechanical ventilation which is an accepted parameter used
in most of the similar studies while using 28 days ventilator
free survival might be more accurate.Conﬂict of interest
All Authors are declaring that they do not have conﬂict of
interest related to this study.References
[1] S. Nseir, C. Di Pompeo, P. Pronnier, et al, Nosocomial
tracheobronchitis in mechanically ventilated patients:
incidence, aetiology and outcome, Eur. Respir. J. 20 (2002) 1483.
[2] D.J. Weber, W.A. Rutala, E.E. Sickbert-Bennett, et al,
Microbiology of ventilator-associated pneumonia compared
with that of hospital-acquired pneumonia, Infect. Control
Hosp. Epidemiol. 28 (2007) 825.
[3] M.H. Kollef, L.E. Morrow, M.S. Niederman, et al, Clinical
characteristics and treatment patterns among patients with
ventilator-associated pneumonia, Chest 129 (2006) 1210.
[4] E. Tejerina, F. Frutos-Vivar, M.I. Restrepo, et al, Incidence, risk
factors, and outcome of ventilator-associated pneumonia, J.
Crit. Care 21 (2006) 56–65.
[5] Ali A. El-Solh, Ahmad Alhajhusain, Philippe Abou Jaoude,
Paul Drinka, Validity of severity scores in hospitalized patients
with nursing home-acquired pneumonia, Chest 138 (6) (2010)
1371–1376.
[6] Marya D. Zilberberg, Andrew F. Shorr, Ventilator-associated
pneumonia: the clinical pulmonary infection score as a surrogate
for diagnostics and outcome, Clin. Infect. Dis. 51 (1) (2010)
S131–S135.
[7] Wen-Feng Fang, Kuang-Yao Yang, Chieh-Liang Wu, Chong-
Jen Yu, Chang-Wen Chen, Chih-Yen Tu, Meng-Chih Lin,
Application and comparison of scoring indices to predict
outcomes in patients with healthcare-associated pneumonia,
Crit. Care 15 (2011) R32.
[8] D. Aujesky, T.E. Auble, D.M. Yealy, et al, Prospective
comparison of three validated prediction rules for prognosis in
Predictive value of different scoring systems for critically ill patients with hospital acquired pneumonia 763community-acquired pneumonia, Am. J. Med. 118 (4) (2005)
384–392.
[9] Mitchell, Richard Sheppard, Kumar, et al, Robbins Basic
Pathology, eighth ed., vol. 160 (8), Saunders, Philadelphia, 2007,
pp. 973–977.
[10] Sharma, Maycher, Eschun, et al, Radiological imaging in
pneumonia: recent innovations, Curr. Opin. Pulm. Med. 13 (3)
(2007) 159–169.
[11] D.C. Krause, M.F. Balish, Cellular engineering in a minimal
microbe: structure and assembly of the terminal organelle of
Mycoplasma pneumonia, Mol. Microbiol. 51 (4) (2004) 917–924.[12] T.D. Girard, G.R. Bernard, Mechanical ventilation in ARDS: a
state-of-the-art review, Chest 131 (3) (2007) 921–929.
[13] W.S. Lim, M.M. van der Eerden, R. Laing, W.G. Boersma, N.
Karalus, G.I. Town, S.A. Lewis, J.T. Macfarlane, Deﬁning
community acquired pneumonia severity on presentation to
hospital: an international derivation and validation study,
Thorax 58 (2003) 377–382.
[14] Saldı´as, J.I. Me´ndez, Ramı´rez, et al, Predictive value of history
and physical examination for the diagnosis of community-
acquired pneumonia in adults, Rev. Med. Chile 135 (4) (2007)
517–528.
